Phibro Animal Health (PAHC) Misses Q3 EPS by 4c, FY Guidance Comes in Light
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Nasdaq ticks up as tech stocks steady; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude jumps to highest since April on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Nokia shares fall despite earnings beat on cash flow concerns
Phibro Animal Health Corporation Reports Third Quarter Results
May 6, 2019 4:20 PM EDTTEANECK, N.J., May 06, 2019 (GLOBE NEWSWIRE) -- Phibro Animal Health Corporation (NASDAQ: PAHC) today announced its financial results for its third quarter ended March 31, 2019.
Highlights for the March 2019 quarter (compared to the March 2018 quarter)
Net sales of $206 million, a decrease of $3 million, or 2%Net income of $15 million, a decrease of $5 millionDiluted EPS of $0.37, a decrease of $0.12Adjusted EBITDA of $30 million, a decrease of $3.4 million, or 10%Adjusted diluted EPS of $0.39, a decrease of $0.07, or 15%Phibro also updated its full year financial guidance, to include:
... More


